Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Kronos Bio, Inc. (KRON) had Weighted-Average Shares Outstanding (Diluted) of 60.07M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$2.27M |
|
$-25.81M |
|
-- |
|
$2.27M |
|
$29.42M |
|
$-27.15M |
|
$1.34M |
|
$-25.81M |
|
$-25.81M |
|
$-25.81M |
|
$-25.81M |
|
$-25.81M |
|
$-25.81M |
|
$-27.15M |
|
$-27.12M |
|
60.07M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
60.07M |
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$115.23M |
|
$3.82M |
|
$9.13M |
|
$124.36M |
|
$15.28M |
|
-- |
|
$21.51M |
|
$36.78M |
|
$87.58M |
|
$87.58M |
|
$87.58M |
|
60.46M |
|
| Cash Flow Statement Financials | |
$-65.44M |
|
$85.44M |
|
$0.24M |
|
$66.35M |
|
$86.60M |
|
$20.25M |
|
$9.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1196.21% |
|
-1196.21% |
|
-- |
|
-1137.14% |
|
-1137.14% |
|
$-65.44M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-29.47% |
|
-29.47% |
|
-20.76% |
|
-29.47% |
|
$1.45 |
|
$-1.09 |
|
$-1.09 |
|